# LMC Diabetes & Endocrinology Ltd.: Observational study completed, 3392 enrolled (Diabetes (DM), Type 2 Diabetes)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | LMC Diabetes & Endocrinology Ltd. |
| Sponsor type | Academic and hospital |
| Study | Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes |
| NCT ID | NCT07424430 |
| Phase | Observational |
| Status | completed |
| Conditions | Diabetes (DM); Type 2 Diabetes; Obesity (Disorder) |
| Intervention types | drug |
| Target enrollment | 3392 |
| Site countries | Canada |
| Posted | 2026-02-20 |
| Planned start | 2026-02-20 |
| Event | Completed |
| Event date | 2026-09-28 |
| Last update posted | 2026-10-13 |

## Why this score
- Completed: closeout, analysis and the next study ahead.
- 3392 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07424430). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.